- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/08 - AntiepilepticsAnticonvulsants
Patent holdings for IPC class A61P 25/08
Total number of patents in this class: 2868
10-year publication summary
|
88
|
147
|
242
|
216
|
270
|
297
|
237
|
214
|
263
|
155
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 147 |
103 |
| Jazz Pharmaceuticals Research UK Limited | 258 |
75 |
| Xenon Pharmaceuticals Inc. | 194 |
51 |
| Taisho Pharmaceutical Co., Ltd. | 846 |
42 |
| The Regents of the University of California | 20902 |
40 |
| Praxis Precision Medicines, Inc. | 237 |
35 |
| Takeda Pharmaceutical Company Limited | 2700 |
31 |
| Zogenix International Limited | 71 |
29 |
| Katholieke Universiteit Leuven | 1305 |
28 |
| Hoffmann-La Roche Inc. | 3841 |
25 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 188 |
25 |
| F. Hoffmann-La Roche AG | 7798 |
21 |
| Sage Therapeutics, Inc. | 210 |
21 |
| Centre National de La Recherche Scientifique | 11111 |
19 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3324 |
19 |
| Janssen Pharmaceutica N.V. | 3147 |
18 |
| The Johns Hopkins University | 5938 |
17 |
| Otsuka Pharmaceutical Co., Ltd. | 1510 |
17 |
| Sumitomo Dainippon Pharma Co., Ltd. | 210 |
16 |
| Immedica Pharma US Inc. | 40 |
16 |
| Other owners | 2220 |